Ethical Approaches to Limiting Overall Costs for Glucagon-Like Peptide-1 Receptor Agonists for Weight Management2025-01-010 PRE AI JJohan Dellgren EEzekiel Emanuel *GGovind Persad DOI:10.7326/ANNALS-24-01317OriginalOriginal request for helpShareSaveAbstract En